Cancers of the upper urinary tract are relatively rare—approximately 3,000 cases are diagnosed each year in the United States. These tumors, most commonly urethelial carcinoma, develop in the lining of the renal pelvis and ureter, the structures which collect and transmit urine towards the bladder.
According to Michael Leapman, MD, a Yale Medicine urologic oncologist, “Patients who are newly diagnosed with upper tract cancers may feel worried about their prognosis and treatment options. Our team is ideally suited to help care for these individuals by offering a collaborative, multi-disciplinary, approach to care, offering expertise from urologic surgeons and medical oncologists," he says.
Our physicians are at the forefront of clinical care and research into the latest treatments for this disease, including minimally invasive surgical approaches such as endoscopic resection, laparoscopic, robotic-assisted and open approaches as well as chemotherapy or access to clinical trials for appropriately selected patients. At Yale Medicine, we are at the forefront of clinical care and research into the latest treatments for this disease.